KPIT Technologies: JPMorgan ₹1,400 target for FY26

JPMorgan holds ‘Overweight’ as KPIT stock turns volatile

JPMorgan has reiterated its top ‘Overweight’ rating on KPIT Technologies while maintaining a price target of ₹1,400. The reiteration comes after a sharp correction in the stock that has reopened the debate on near-term earnings visibility versus long-term growth expectations. KPIT, positioned as an automotive software engineering player, has been navigating a period of heightened sensitivity to guidance commentary and deal momentum. The recent slide in the KPIT share price was linked to cautious business updates, macro uncertainty, and multiple brokerage actions. Investors have also weighed the latest quarterly profit decline against the company’s topline trajectory. In JPMorgan’s view, the magnitude of the price reaction did not reflect a fundamental shift. But the brokerage also flagged that the next few quarters will likely need stronger proof points.

What triggered the sharp fall in KPIT share price

KPIT’s stock saw a sharp fall of over 10% in a single trading session, which became the immediate reference point for the latest broker notes. The correction was attributed to slower deal conversions and a more cautious tone in business updates, followed by downgrades and price target cuts from global brokerages. The market reaction also came amid broader uncertainty that has affected IT and engineering R&D-linked companies. The debate in KPIT’s case has centered on how quickly demand and deal execution can re-accelerate. Investors have been reassessing the company’s near-term growth visibility, especially after mixed quarterly prints. Broker commentary also pointed to slower ramp-ups in parts of the portfolio, which can translate into weaker sequential momentum. As a result, sentiment turned cautious despite long-term growth forecasts being described as strong.

Q1 FY26 results: profit decline offsets growth narrative

KPIT’s June quarter (Q1 FY26) results were described as mixed, with strong top-line growth commentary being overshadowed by a sharp decline in reported profitability. Reported net profit for the quarter ended June 30, 2025, came in at ₹171.8 crore to ₹171.9 crore, down about 15.8% to nearly 16% year-on-year. The year-ago net profit number cited was ₹204.2 crore. Sequentially, profit fell 29.7% from ₹244.7 crore. The decline was linked to the absence of a large exceptional income that had supported the same quarter in the previous year. The results contributed to investor disappointment, with the stock falling nearly 3% in the post-results session referenced. During that session, the stock touched an intra-day low of ₹1,233 and was trading at ₹1,250.8 at 1:45 PM, down 1.4% on the NSE.

JPMorgan’s ₹1,400 target: what changed and what didn’t

Investing.com reported that JPMorgan reduced its price target on KPIT Technologies to ₹1,400 from ₹1,500 while maintaining its Overweight rating. The revision followed a 10% drop in the stock price on September 30, with JPMorgan stating it saw no fundamental reason for such a sharp reaction. JPMorgan noted the stock had aligned with broader IT underperformance, with KPIT down 25% year-to-date compared with the Nifty IT index’s 22% decline. For FY26, the brokerage expects a challenging year, estimating about 1% organic revenue de-growth. It also forecasts a rebound to 12% growth in FY27 and 16% in FY28. JPMorgan cut its revenue and EPS estimates by 4% to 6% across FY26 to FY28 as it moderated recovery expectations. The updated target reflected a reduced multiple of 36x versus 40x earlier and implied a 1.9x PEG ratio for FY26 to FY28 earnings, compared with 1.7x for growth champions in the sector.

A ‘show me’ stock: proof points JPMorgan wants

JPMorgan characterized KPIT as a “show me” stock, meaning the next phase of stock performance depends more on evidence than on narrative. The brokerage indicated that future rallies may require tangible proof points such as quarter-on-quarter revenue growth acceleration and large deal wins. This framing matters because it places execution milestones at the center of investor expectations. It also aligns with the market’s recent reaction to cautious updates on deal conversions. In such a setup, quarterly progression can become the key driver of sentiment and valuation. The brokerage’s emphasis suggests that near-term volatility may continue when guidance signals are conservative. At the same time, the maintained Overweight rating indicates JPMorgan still sees merit in the longer-term positioning. The price target cut, in this reading, is more about tempering assumptions than changing the core view.

Goldman Sachs and other broker calls in focus

Goldman Sachs maintained a ‘Neutral’ rating while trimming its price target, citing concerns around slower ramp-up of the newly acquired Caresoft Global business and a delayed recovery in EV R&D cycles. It also expects KPIT’s organic revenue to decline sequentially in the upcoming September quarter. Domestic brokerages cited in the article were more constructive. Axis Securities has given a ‘Buy’ rating with a target of ₹1,385, citing expectations of stronger recovery supported by a robust deal pipeline, new partnerships, and increased adoption of new-age technologies. Choice Broking maintained an ‘Add’ rating with a target price of ₹1,400. The cluster of targets around the ₹1,385 to ₹1,400 zone signals that multiple houses are anchoring valuation close to the same level despite differing near-term growth assumptions. But the difference in ratings shows the debate remains centered on timing and visibility rather than the addressable market.

Another JPMorgan note cited ₹1,900: separating the timelines

The provided text also references a separate JPMorgan action where the brokerage lowered its target price to ₹1,900 per share after KPIT revised its FY25 constant currency revenue growth outlook to the lower end of its 18% to 22% range. In that context, delays in deal ramp-ups and closures, and higher offshoring for client cost efficiency, were cited as factors behind a softer second half and potential spillover into FY26. KPIT also projected FY25 EBITDA margins closer to 21%, slightly higher than earlier guidance of 20.5%. JPMorgan was reported to have reduced revenue and earnings estimates by 3% to 6% in that note, leading to a 5% cut in the price target. The same set of references noted the stock dropped as much as 15% on October 24 and traded at ₹1,414 at 12:23 PM, down 13.5%. Another line said KPIT’s share price fell 20% over the week ended October 25. These details appear to reflect a different market episode than the ₹1,400 target update and are best read as separate points in the stock’s recent volatility.

Key figures and broker targets at a glance

Market impact: valuation resets and tighter near-term scrutiny

The most immediate market impact has been a re-pricing of KPIT amid slower near-term visibility, even as long-term expectations remain part of broker models. JPMorgan’s move to a 36x target multiple from 40x illustrates how quickly valuation assumptions can change when growth expectations are moderated. The stock’s alignment with the broader IT sector downturn, including the year-to-date underperformance numbers cited, has reinforced a macro overlay on KPIT’s trading pattern. The quarterly profit decline also mattered because reported profit was a visible miss for investors focused on near-term delivery. Meanwhile, the mix of global and domestic broker views indicates the market is splitting the story into two tracks: structural auto ER&D demand and near-term execution. The presence of multiple price targets around ₹1,400 suggests the market is trying to establish a new valuation anchor after the drawdown. In practical terms, the stock’s next moves are likely to be shaped by updates on deal ramp-ups, large wins, and sequential growth trends, as highlighted by broker commentary.

Analysis: why the ‘proof points’ framing matters

KPIT’s recent volatility shows how quickly investor focus can shift from multi-year themes to quarter-by-quarter execution. JPMorgan’s “washout year” language for FY26, paired with forecasts of a rebound in FY27 and FY28, sets up a transition period where the market demands clearer evidence of acceleration. The brokerage’s “show me” framing also echoes concerns raised by Goldman Sachs around slower ramp-up and EV R&D cycle timing. In such periods, valuation becomes more sensitive to changes in assumptions, which is reflected in reduced multiples and lowered estimates. At the same time, maintained Overweight and Buy recommendations from some houses show that brokers still see KPIT as relevant to automotive software engineering demand. The disagreement is largely about timing of recovery, not the category itself. For investors, the story has become more about monitoring tangible triggers rather than relying on broad sector narratives.

Conclusion: focus shifts to execution and sequential momentum

JPMorgan’s reiterated Overweight rating and ₹1,400 price target place KPIT in a zone where long-term optimism remains, but near-term scrutiny is higher. The profit decline in Q1 FY26 and cautious commentary on deal conversion have been central to the recent stock correction. Brokerages have also highlighted near-term risks such as slower ramp-ups and delayed recovery in EV R&D cycles. Going forward, the key markers remain those cited by JPMorgan: quarter-on-quarter revenue growth acceleration and evidence of large deal wins. Investors are likely to track subsequent quarterly updates closely for confirmation of whether FY26 plays out as a difficult year or stabilizes sooner. Any future brokerage revisions or company guidance updates will remain important for sentiment given the recent sensitivity in the share price.